Today we feature studies to be presented at the year's most important cancer conference, the upcoming American Society of ...

Genomic Testing Cooperative, a molecular diagnostics company advancing comprehensive cancer profiling through DNA and RNA ...

Genomic profiling can help personalize cancer care, but patients may not be offered these tests due to a burdensome ...

Upcoming presentations at the ASCO meeting in Chicago highlight potential practice-changing studies in cancer care.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

On-site automated NGS using circulating tumor DNA enabled comprehensive genomic testing in ~27 hours, substantially shortening the interval between diagnosis and potential targeted-therapy selection.

Researchers conducted a cross-sectional electronic survey to see whether respondents were offered and completed germline ...

Cancer treatment is becoming more personalized. By considering a patient's unique genetic and molecular profile, along with their lifestyle and environmental factors, doctors can make more accurate ...

Health experts say testing can help doctors identify people who may benefit from earlier screenings, additional imaging, or ...

Tens of thousands of patients will be able to check whether they are at risk of developing cancer as the NHS creates a first-of-its-kind database for genes linked to the disease. The health service ...

SINGAPORE—For many patients across Asia, a cancer diagnosis often begins a difficult search, not only for treatment, but for ...